Mangodlay, Nick Klenton B.
HRN: 26-24-79 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
11/20/2024
11/27/2024
IV
450
Q8
Bowel Obstruction
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes